Polyrotaxane-Based Supramolecular Material for Improvement of Pharmaceutical Properties of Protein Drugs
Authors:
- 31 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (7) , 2116-2120
Abstract
No abstract availableKeywords
Funding Information
- Takeda Science Foundation
- Research Center for Biomedical Engineering
- Naito Foundation
This publication has 18 references indexed in Scilit:
- Threaded macromolecules as a versatile framework for biomaterialsChemical Communications, 2014
- Therapeutic protein aggregation: mechanisms, design, and controlTrends in Biotechnology, 2014
- Improvement of pharmaceutical properties of insulin through conjugation with glucuronylglucosyl-β-cyclodextrinJournal of Inclusion Phenomena and Macrocyclic Chemistry, 2014
- Molecular logistics using cytocleavable polyrotaxanes for the reactivation of enzymes delivered in living cellsScientific Reports, 2013
- Trehalose Glycopolymers as Excipients for Protein StabilizationBiomacromolecules, 2013
- Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bagsAmerican Journal of Health-System Pharmacy, 2010
- Protein drug stability: a formulation challengeNature Reviews Drug Discovery, 2005
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997
- Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to MiceJournal of Pharmaceutical Sciences, 1994
- The molecular necklace: a rotaxane containing many threaded α-cyclodextrinsNature, 1992